These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 9934666
21. Thorny issues in the ethics of AIDS vaccine trials. Berkley S. Lancet; 2003 Sep 20; 362(9388):992. PubMed ID: 14513850 [No Abstract] [Full Text] [Related]
22. The challenges of an HIV vaccine enterprise. Wolf H. Science; 2004 Feb 27; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14991961 [No Abstract] [Full Text] [Related]
23. New guidelines on ethical considerations in HIV preventive vaccine research. Patterson D. Can HIV AIDS Policy Law Newsl; 2000 Feb 27; 5(2-3):20-4, 21-4. PubMed ID: 11833190 [Abstract] [Full Text] [Related]
24. Microbicide research in developing countries: have we given the ethical concerns due consideration? Moodley K. BMC Med Ethics; 2007 Sep 19; 8():10. PubMed ID: 17877834 [Abstract] [Full Text] [Related]
26. Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccines: report from a WHO-UNAIDS Consultation 13-15 March 2001, Geneva, Switzerland. AIDS; 2002 Jul 05; 16(10):W15-25. PubMed ID: 12131232 [Abstract] [Full Text] [Related]
29. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia. Rerks-Ngarm S, Pitisuttithum P, Ganguly N, Zhang L, Tamashiro H, Cooper DA, Vun MC, Bela B, Ditangco R, Van Kinh N, Bernstein A, Osmanov S, Mathieson B, Kent SJ, Shao Y. Curr Opin HIV AIDS; 2010 Sep 05; 5(5):435-52. PubMed ID: 20978386 [No Abstract] [Full Text] [Related]
30. Status report on HIV vaccine development. Cheonis N. BETA; 1999 Sep 05; 12(4):40-8, 53. PubMed ID: 11367251 [Abstract] [Full Text] [Related]
31. The challenges of HIV vaccine development and testing. Burgers WA, Williamson C. Best Pract Res Clin Obstet Gynaecol; 2005 Apr 05; 19(2):277-91. PubMed ID: 15778116 [Abstract] [Full Text] [Related]
32. Ethical issues in AIDS vaccine development. Bloom BR. AIDS Patient Care STDS; 1999 May 05; 13(5):273-80. PubMed ID: 10356806 [No Abstract] [Full Text] [Related]
36. Resolving legal, ethical, and human rights challenges in HIV vaccine research. Patterson D. Can HIV AIDS Policy Law Rev; 2000 May 05; 5(4):60-6. PubMed ID: 11833175 [Abstract] [Full Text] [Related]
37. AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines. Kent SJ, Cooper DA, Chhi Vun M, Shao Y, Zhang L, Ganguly N, Bela B, Tamashiro H, Ditangco R, Rerks-Ngarm S, Pitisuttithum P, Van Kinh N, Bernstein A, Osmanov S, AIDS Vaccine for Asia Network investigators and supporters. PLoS Med; 2010 Sep 21; 7(9):e1000331. PubMed ID: 20877474 [Abstract] [Full Text] [Related]
38. Medicine. The need for a global HIV vaccine enterprise. Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, Berkley S, Haynes BF, Baltimore D, Collins C, Douglas RG, Esparza J, Francis DP, Ganguly NK, Gerberding JL, Johnston MI, Kazatchkine MD, McMichael AJ, Makgoba MW, Pantaleo G, Piot P, Shao Y, Tramont E, Varmus H, Wasserheit JN. Science; 2003 Jun 27; 300(5628):2036-9. PubMed ID: 12829768 [Abstract] [Full Text] [Related]
39. Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence. Newman PA, Rubincam C. Expert Rev Vaccines; 2014 Dec 27; 13(12):1553-62. PubMed ID: 25174764 [Abstract] [Full Text] [Related]
40. G-8 endorses new global HIV vaccine enterprise. Bull World Health Organ; 2004 Jul 27; 82(7):557. PubMed ID: 15500292 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]